<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05102825</url>
  </required_header>
  <id_info>
    <org_study_id>H19-01163</org_study_id>
    <nct_id>NCT05102825</nct_id>
  </id_info>
  <brief_title>Imaging Measures of Respiratory Health Registry</brief_title>
  <acronym>iMRH</acronym>
  <official_title>Imaging Measures of Respiratory Health Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, observational cohort registry that aims to collect data on pulmonary&#xD;
      structure and function in healthy people and those with respiratory disease, using structural&#xD;
      and functional pulmonary 1H-MRI and hyperpolarized 129Xe-MRI.&#xD;
&#xD;
      Outcome measures generated from MRI may include but are not limited to measures of regional&#xD;
      ventilation, pulmonary microarchitecture, and regional gas exchange. Additionally, one of the&#xD;
      goals of the registry is to facilitate the development of novel image analysis techniques&#xD;
      that have not yet been invented.&#xD;
&#xD;
      These data will be stored along with demographic data, clinical data, and pulmonary function&#xD;
      testing (PFT) data.&#xD;
&#xD;
      This is an open registry. Eligible local and international investigators/institutions can&#xD;
      apply for access.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 11, 2020</start_date>
  <completion_date type="Anticipated">June 1, 2045</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2045</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Structural proton (1H) MRI data</measure>
    <time_frame>no predefined schedule in this open registry study; maximum 25 visits, over up to 25 years</time_frame>
    <description>Includes all proton MRI images collected to assess pulmonary structure. Data may be analysed qualitatively and quantitatively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional proton (1H) MRI data</measure>
    <time_frame>no predefined schedule in this open registry study; maximum 25 visits, over up to 25 years</time_frame>
    <description>Includes all proton MRI images collected to assess pulmonary function. Data may be analysed qualitatively and quantitatively.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional hyperpolarized 129-xenon (129Xe) MRI data</measure>
    <time_frame>no predefined schedule in this open registry study; maximum 25 visits, over up to 25 years</time_frame>
    <description>Includes all proton images collected to assess pulmonary function. Data may be analysed qualitatively and quantitatively.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Resting oxygen saturation</measure>
    <time_frame>no predefined schedule in this open registry study; maximum 25 visits, over up to 25 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CFQ-R Respiratory domain</measure>
    <time_frame>no predefined schedule in this open registry study; maximum 25 visits, over up to 25 years</time_frame>
    <description>Only for participants with cystic fibrosis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>St. George Respiratory Questionnaire</measure>
    <time_frame>no predefined schedule in this open registry study; maximum 25 visits, over up to 25 years</time_frame>
    <description>Only for participants with Respiratory disease.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Respiratory Disease</condition>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Respiratory Disease</arm_group_label>
    <description>Any physician-diagnosed lung disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy</arm_group_label>
    <description>Healthy control with no physician-diagnosed lung disease</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>1H and Xe-129 MRI</intervention_name>
    <description>Traditional 1H-MRI (room air inhalation) and Xe-129 MRI (requires inhalation of Xenon 129 gas).</description>
    <arm_group_label>Healthy</arm_group_label>
    <arm_group_label>Respiratory Disease</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Eligible individuals with respiratory disease will be identified from various Respiratory&#xD;
        Medicine or subspecialty clinics at British Columbia Children's Hospital (BCCH) or from&#xD;
        analogous clinics at St Paul's Hospital (SPH). Participants may be contacted using a First&#xD;
        Contact Letter, or permission to approach will be obtained by a member of their circle of&#xD;
        care.&#xD;
&#xD;
        Healthy participants will be recruited from family members of patients in the Division of&#xD;
        Respiratory Medicine at BCCH and SPH as well as from the community or other clinics using&#xD;
        flyers or a First Contact Letter.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Respiratory Disease&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          1. Physician-diagnosed lung disease - based on a diagnosis made by a treating staff&#xD;
             physician and confirmed by the principal investigator.&#xD;
&#xD;
          2. Age 0-99 years.&#xD;
&#xD;
          3. Informed consent by participant, parent, or legal guardian&#xD;
&#xD;
          4. In the opinion of the Investigator, the participant will likely be able to perform&#xD;
             maneuvers to obtain technically acceptable pulmonary XeMRI images.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Physical findings at screening that, in the opinion of the Investigator, would&#xD;
             compromise the safety of the participant or the quality of the research data.&#xD;
&#xD;
          2. Requirement of supplementary oxygen to maintain an oxygen saturation above 95%.&#xD;
&#xD;
          3. Failed MRI screening form.&#xD;
&#xD;
          4. History of claustrophobia.&#xD;
&#xD;
          5. Known current pregnancy or lactation.&#xD;
&#xD;
        Healthy&#xD;
&#xD;
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 0-99 years&#xD;
&#xD;
          2. Informed consent by participant, parent, or legal guardian&#xD;
&#xD;
          3. In the opinion of the Investigator, the participant will likely be able to perform&#xD;
             maneuvers to obtain technically acceptable pulmonary MRI images.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Physician-diagnosed lung disease.&#xD;
&#xD;
          2. Failed MRI screening form.&#xD;
&#xD;
          3. History of claustrophobia.&#xD;
&#xD;
          4. Physical findings at screening that, in the opinion of the Investigator, would&#xD;
             compromise the safety of the participant or the quality of the research data.&#xD;
&#xD;
          5. Known current pregnancy or lactation.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonathan Rayment, MDCM, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of British Columbia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rodrigo Sandoval, MSc</last_name>
    <phone>6048752345</phone>
    <phone_ext>2928</phone_ext>
    <email>Rodrigo.Sandoval@bcchr.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>British Columbia Children's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6H 3N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rodrigo Sandoval, MSc</last_name>
      <phone>6048752345</phone>
      <phone_ext>2928</phone_ext>
      <email>Rodrigo.Sandoval@bcchr.ca</email>
    </contact>
    <contact_backup>
      <last_name>Alam Lakhani</last_name>
      <phone>6048752345</phone>
      <phone_ext>7606</phone_ext>
      <email>alam.lakhani@cw.bc.ca</email>
    </contact_backup>
    <investigator>
      <last_name>Jonathan Rayment, MDCM, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Paul's Hospital</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6Z 1Y6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Don Sin, MD MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 27, 2021</study_first_submitted>
  <study_first_submitted_qc>October 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 2, 2021</study_first_posted>
  <last_update_submitted>October 29, 2021</last_update_submitted>
  <last_update_submitted_qc>October 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Jonathan Rayment</investigator_full_name>
    <investigator_title>Clinical Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>iMRH-Registry Data may be shared with investigators from BCCHR/UBC or elsewhere. iMRH-Registry Co-Investigaotrs using iMRH Registry Data to address the Scientific Objectives of the iMRH Registry do not need to formally apply for access. All other User-Investigators (domestic and international) must apply to the iMRH-Registry Data Access Committee for access to the iMRH-Registry Data.</ipd_description>
    <ipd_access_criteria>Criteria for access to the iMRH-Registry Data:&#xD;
The Proposed Study must demonstrate approval by a Qualified REB&#xD;
The objectives of the Proposed Study must align with the scientific objectives of the iMRH-Registry (see ยง5)&#xD;
Use of the iMRH Registry Data in the Proposed Study must respect the informed consent given by the participants of the iMRH Registry;&#xD;
The Proposed Study must have scientific merit, as assessed by the iMRH Registry Data Access Committee&#xD;
The User-Investigator must demonstrate sufficient funding to perform the Proposed Study.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

